Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
Jordan Weinstein, Louis Girard, Serge Lepage, Robert S. McKelvie, Karthik Tennankore
Abstract
KEY POINTS Hyperkalemia, defined as a serum potassium level of 5.0 mmol/L or greater, can lead to severe electrophysiological disturbances, including cardiac arrythmias, that increase morbidity and risk of death.[1][1] It is common in patients with conditions that impair potassium excretion by the
Topics & Concepts
HyperkalemiaAldosteroneRenin–angiotensin systemMedicinePotassiumInternal medicineEndocrinologyCardiologyPharmacologyChemistryBlood pressureOrganic chemistryPotassium and Related DisordersHeart Failure Treatment and ManagementPharmaceutical Practices and Patient Outcomes